Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035412 · ClinicalTrials.gov registry record · Phase 2
St. John's Wort Versus Placebo in Social Phobia
A Phase 2 study of Phobic Disorders, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00035412 is a Phase 2 study of Phobic Disorders that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 40 participants, below the 113-participant average among 5 other Phobic Disorders trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00035412, a Phase 2 study of Phobic Disorders, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of St. John's Wort as compared to placebo (an inactive substance) in the treatment of outpatients with social phobia.
Conditions Studied
Interventions
- DRUG St. John's Wort
Study Locations (1)
Wisconsin
- The Dean Foundation for Health, Research, and Education - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2001-12 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035412
The ClinicalTrials.gov registry entry for NCT00035412 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 5 other Phobic Disorders trials with a reported enrollment target (65% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phobic Disorders appearing as the primary indexed condition, and to 1 intervention - of which St. John's Wort is the first listed.
NCT00035412 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00035412 about?
NCT00035412 is a clinical study titled "St. John's Wort Versus Placebo in Social Phobia". The purpose of this study is to determine the effectiveness of St. John's Wort as compared to placebo (an inactive substance) in the treatment of outpatients with social phobia.
What is the current status of trial NCT00035412?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2001-12. Estimated completion is 2004-08.
What conditions does trial NCT00035412 study?
This clinical trial studies the following conditions: Phobic Disorders.
What interventions are being tested in trial NCT00035412?
The interventions under investigation include: St. John's Wort (DRUG).
Who is sponsoring clinical trial NCT00035412?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00035412 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phobic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
COMPLETED · Phase 2
-
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
COMPLETED · Phase 2
-
Reward Processing and Exposure Therapy for Social Anxiety Disorder
RECRUITING · NA
-
Treatment for Specific Phobias in Children
COMPLETED · Phase 1
-
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.